A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models ; volume:23 ; number:1 ; day:2 ; month:6 ; year:2023 ; pages:1-9 ; date:12.2023
BMC cancer ; 23, Heft 1 (2.6.2023), 1-9, 12.2023
- Creator
-
Mrdenovic, Stefan
Wang, Yanping
Yin, Lijuan
Chu, Gina Chia-Yi
Ou, Yan
Lewis, Michael S.
Heffer, Marija
Posadas, Edwin M.
Zhau, Haiyen E.
Chung, Leland W. K.
Edderkaoui, Mouad
Pandol, Stephen J.
Wang, Ruoxiang
Zhang, Yi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10878-3
- URN
-
urn:nbn:de:101:1-2023091313041334016200
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mrdenovic, Stefan
- Wang, Yanping
- Yin, Lijuan
- Chu, Gina Chia-Yi
- Ou, Yan
- Lewis, Michael S.
- Heffer, Marija
- Posadas, Edwin M.
- Zhau, Haiyen E.
- Chung, Leland W. K.
- Edderkaoui, Mouad
- Pandol, Stephen J.
- Wang, Ruoxiang
- Zhang, Yi
- SpringerLink (Online service)
Other Objects (12)
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
A Tick Cysteine Protease Inhibitor RHcyst-1 Exhibits Antitumor Potential
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
A variant of guanidine-IV riboswitches exhibits evidence of a distinct ligand specificity
Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy
Exhibits
Exhibits
Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
A Tick Cysteine Protease Inhibitor RHcyst-1 Exhibits Antitumor Potential
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
A variant of guanidine-IV riboswitches exhibits evidence of a distinct ligand specificity
Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy
Exhibits
Exhibits
Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
A Tick Cysteine Protease Inhibitor RHcyst-1 Exhibits Antitumor Potential
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
A variant of guanidine-IV riboswitches exhibits evidence of a distinct ligand specificity
Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy
Exhibits
Exhibits
Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab